Skip to main content
. Author manuscript; available in PMC: 2009 May 7.
Published in final edited form as: Brain Res. 2008 Mar 10;1208:192–203. doi: 10.1016/j.brainres.2008.02.093

Fig. 1.

Fig. 1

Immunoblot showing expression of GMF in Aβ1-42 injected mice brains. Two mice in each group at day 7, 14, and 21 post injections were analyzed by Western blot using an affinity-purified monoclonal antibody (CT-11) against a synthetic peptide corresponding to the C-terminal 11 amino acid residues of GMF. β-actin was included for sample control. The figure is representing three independent experiments.

HHS Vulnerability Disclosure